Last Updated : October 27, 2012
Details
FilesGeneric Name:
Rivaroxaban
Project Status:
Complete
Therapeutic Area:
Deep-vein thrombosis without symptomatic pulmonary embolism
Manufacturer:
Bayer Inc.
Brand Name:
Xarelto
Project Line:
Reimbursement Review
Project Number:
SF0295-000
Submission Type:
Request For Advice
Indications:
Deep-Vein Thrombosis (treatment), without Symptomatic Pulmonary Embolism
Files
Last Updated : October 27, 2012